2015
DOI: 10.1016/j.jocn.2015.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Decreased dopaminergic treatment of hospitalized Parkinson’s disease patients during infectious diseases is associated with poor outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
2
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 8 publications
2
2
0
Order By: Relevance
“…The present study expands the current literature regarding prognostic factors associated with PD patients' deterioration and survival. It further reinforces the findings of a previous, smaller cohort analysis published earlier [5]. Decreased dopaminergic treatment was found to be a widespread phenomenon during PD patients' hospitalizations, occurring in more than half of the population (50.7%).…”
supporting
confidence: 89%
See 2 more Smart Citations
“…The present study expands the current literature regarding prognostic factors associated with PD patients' deterioration and survival. It further reinforces the findings of a previous, smaller cohort analysis published earlier [5]. Decreased dopaminergic treatment was found to be a widespread phenomenon during PD patients' hospitalizations, occurring in more than half of the population (50.7%).…”
supporting
confidence: 89%
“…The investigators of this study hypothesized that patients with PD might have worse prognosis when hospitalized due to infections due to dopaminergic treatment under-dose. These assumptions were confirmed in a previous analysis of a smaller cohort [5]. The main clinical outcomes were in-hospital mortality and worse discharge destination after hospitalizations (defined as worse in any case that the patient arrived from home and was discharged to a nursing home, rehabilitation facility, or was referred to chronic hospitalization).…”
supporting
confidence: 57%
See 1 more Smart Citation
“…The dose of LED increased during hospitalization, although the change did not reach statistical significance. A recent report suggested that a reduction in LED during hospitalization was significantly associated with increased in-hospital mortality and worse discharge destination [10] . Thus, reduced LED could potentially worsen motor disability at discharge, leading to increasing costs for patients' care.…”
Section: Discussionmentioning
confidence: 99%